Evidence map›Paper›PMID 23106931›Full record

Trial reportAddiction (Abingdon, England)2012

Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.

Laura F McNicholas, Amber M Holbrook, Kevin E O'Grady, Hendrée E Jones, Mara G Coyle, Peter R Martin, Sarah H Heil, Susan M Stine, Karol Kaltenbach

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Laura F McNicholasDepartment of Veterans Affairs, Philadelphia VA Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Amber M Holbrook
Kevin E O'Grady
Hendrée E Jones
Mara G Coyle
Peter R Martin
Sarah H Heil
Susan M Stine
Karol Kaltenbach
Thomas Jefferson University · USBrown University · USJohns Hopkins Medicine · USPhiladelphia VA Medical Center · USUniversity of Maryland, College Park · USUniversity of Vermont · USVanderbilt University · USWayne State University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI MAY, JAMES M. · 1985 to 2008
$38.3M
WEIGHT MAINTENANCE AND PSYCHOLOGICAL BENEFITS OF EXERCISEM01RR000109 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI KIRKPATRICK, BETH DIANE · 1985 to 2010
$24.3M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015764 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JONES, HENDREE E · 2004 to 2008
$5.8M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015738 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI KALTENBACH, KAROL A · 2004 to 2008
$3.6M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015832 · NIDA · WAYNE STATE UNIVERSITY · PI STINE, SUSAN M · 2004 to 2009
$2.2M
Maternal Opioid Treatment: Human Experimental ResearchR01DA018410 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H · 2004 to 2008
$2.2M
Maternal Opioid Treatment: Human ExperimentalR01DA018417 · NIDA · MEDICAL UNIVERSITY OF VIENNA · PI FISCHER, GABRIELE · 2004 to 2008
$1.8M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015778 · NIDA · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI LESTER, BARRY M. · 2004 to 2009
$1.6M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015741 · NIDA · ST. JOSEPH'S HEALTH CENTRE · PI SELBY, PETER L · 2004 to 2008
$643k
NCRR NIH HHS M01 RR000109NCRR NIH HHS M01 RR 00095NCRR NIH HHS M01 RR 109NCRR NIH HHS UL1 RR024975NIDA NIH HHS R01 DA 015738NIDA NIH HHS R01 DA015738NIDA NIH HHS R01 DA 015741NIDA NIH HHS R01 DA 015764NIDA NIH HHS R01 DA015764NIDA NIH HHS R01 DA 015778NIDA NIH HHS R01 DA015778NIDA NIH HHS R01 DA015832NIDA NIH HHS R01 DA 017513NIDA NIH HHS R01 DA 018410NIDA NIH HHS R01 DA018410NIDA NIH HHS R01 DA 018417NIDA NIH HHS R01 DA018417NIDA NIH HHS R01 DA 15832
6 · The paper itself

Abstract

aimTo examine hepatic enzyme test results throughout the course of pregnancy in women maintained on methadone or buprenorphine.

designParticipants were randomized to either methadone or buprenorphine maintenance. Blood chemistry tests, including liver transaminases and hepatitis C virus (HCV) status, were determined every 4 weeks and once postpartum. As part of a planned secondary analysis, generalized mixed linear models were conducted with aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) as the dependent variables.

settingSix US sites and one European site that provided comprehensive treatment to pregnant opioid-dependent women.

participantsA total of 175 opioid-dependent pregnant women enrolled in the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study.

findingsALT, AST and GGT levels decreased for all subjects across pregnancy trimesters, rising slightly postpartum. HCV-positive subjects exhibited higher transaminases at all time-points compared to HCV-negative subjects, regardless of medication (all Ps < 0.05) condition. Both HCV-positive and negative buprenorphine-maintained participants exhibited lower GGT levels than those who were methadone-maintained (P < 0.05).

conclusionsNeither methadone nor buprenorphine appear to have adverse hepatic effects in the treatment of pregnant opioid-dependent women.

Indexed as

AdolescentAdultAnalgesics, OpioidBuprenorphineFemalegamma-GlutamyltransferaseHepatitis CHumansLinear ModelsLiverLiver Function TestsMethadoneOpiate Substitution TreatmentOpioid-Related DisordersPregnancyPregnancy TrimestersAnalgesics, OpioidBuprenorphinegamma-GlutamyltransferaseMethadoneTransaminases

Identifiers

PMID23106931
PMCPMC4268861
OpenAlexW1640176906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.